APA (7th ed.) Citation

Popova, A. Y., Andreeva, E. E., Babura, E. A., Balakhonov, S. V., Bashketova, N. S., Bulanov, M. V., . . . Totolyan, A. A. (2021). Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation. Infekt͡s︡ii͡a︡ i immunitet, 11(2), 297-323. https://doi.org/10.15789/2220-7619-FOD-1684

Chicago Style (17th ed.) Citation

Popova, A. Yu, et al. "Features of Developing SARS-CoV-2 Nucleocapsid Protein Population-based Seroprevalence During the First Wave of the COVID-19 Epidemic in the Russian Federation." Infekt͡s︡ii͡a︡ I Immunitet 11, no. 2 (2021): 297-323. https://doi.org/10.15789/2220-7619-FOD-1684.

MLA (9th ed.) Citation

Popova, A. Yu, et al. "Features of Developing SARS-CoV-2 Nucleocapsid Protein Population-based Seroprevalence During the First Wave of the COVID-19 Epidemic in the Russian Federation." Infekt͡s︡ii͡a︡ I Immunitet, vol. 11, no. 2, 2021, pp. 297-323, https://doi.org/10.15789/2220-7619-FOD-1684.